Genetically modified human placenta‑derived mesenchymal stem cells with FGF‑2 and PDGF‑BB enhance neovascularization in a model of hindlimb ischemia
about
Therapeutic Potential of Human Mesenchymal Stem Cells for Treating Ischemic Limb DiseasesGene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity.Mesenchymal Stem Cell Therapy for Ischemic TissuesPDGF‑BB promotes the differentiation and proliferation of MC3T3‑E1 cells through the Src/JAK2 signaling pathway
P2860
Genetically modified human placenta‑derived mesenchymal stem cells with FGF‑2 and PDGF‑BB enhance neovascularization in a model of hindlimb ischemia
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Genetically modified human pla ...... n a model of hindlimb ischemia
@ast
Genetically modified human pla ...... n a model of hindlimb ischemia
@en
type
label
Genetically modified human pla ...... n a model of hindlimb ischemia
@ast
Genetically modified human pla ...... n a model of hindlimb ischemia
@en
prefLabel
Genetically modified human pla ...... n a model of hindlimb ischemia
@ast
Genetically modified human pla ...... n a model of hindlimb ischemia
@en
P2093
P2860
P356
P1476
Genetically modified human pla ...... n a model of hindlimb ischemia
@en
P2093
Dongmei Zhang
Guobo Shen
Huashan Shi
Tinghong Ye
Xiancheng Chen
P2860
P304
P356
10.3892/MMR.2015.4089
P577
2015-07-20T00:00:00Z